Preview Mode Links will not work in preview mode

The Moss Report podcast is hosted by science writer Ralph W. Moss, PhD. Guests include leading cancer doctors from around the world, industry professionals, nutritionists, research scientists, naturopaths, patients and more. 

Aug 11, 2020

Dwight McKee, MD, is board-certified in medical oncology, hematology, nutrition, and integrative and holistic medicine. He discusses his lifetime of experience in the cancer world with Dr. Moss.

For more information about Moss Reports, visit mossreports.com 

There are at present no drugs approved specifically to kill [Cancer Stem Cell]s. But, starting around 2015, scientists identified about two dozen natural agents (from foods and herbs) that killed CSCs. Of these, five stand out. Drs. Dwight McKee and Cord Naujokat have called these the “Big Five”:

 

  1. Curcumin is derived from the root stem (rhizome) of the turmeric plant. There are over 5,700+ articles on the topic of curcumin and cancer in  PubMed, the U.S. government’s index of medical journal entries, with new ones appears at a rate of twice every calendar day.
  2. Genistein and other Isoflavones from soybeans and soy products, as well as red clover, and coffee (over 4,712 PubMed articles)
  3. Resveratrol from red grapes skins, plums, berries (3,654 articles)
  4. EGCG (Epigallocatechin-3-gallate), the main solid ingredient in green tea (1,872 PubMed articles)
  5. Sulforaphane and isothiocyanates from cruciferous vegetables such as broccoli and broccoli sprouts (1,085 articles)

 

These “Big Five” are the subject of around 17,000 scientific journal articles relating to cancer. This refutes the notion that such treatments are a fringe phenomenon.

 

According to McKee and Naujokat’s article in the February 27, 2020, Current Medicinal Chemistry:

 

“Since current cancer therapies fail to eradicate CSCs, leading to cancer recurrence and progression, targeting of CSCs with phytochemicals such as curcumin, EGCG, sulforaphane, resveratrol and genistein…may offer a novel therapeutic strategy against cancer.” (14)